S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
pixel
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
Closing prices for crude oil, gold and other commodities
Stocks fall as economic pain deepens, rally runs out of gas
The Latest: Oregon governor blames feds for vaccine delay
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
pixel
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
Closing prices for crude oil, gold and other commodities
Stocks fall as economic pain deepens, rally runs out of gas
The Latest: Oregon governor blames feds for vaccine delay
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
pixel
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
Closing prices for crude oil, gold and other commodities
Stocks fall as economic pain deepens, rally runs out of gas
The Latest: Oregon governor blames feds for vaccine delay
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
pixel
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
Closing prices for crude oil, gold and other commodities
Stocks fall as economic pain deepens, rally runs out of gas
The Latest: Oregon governor blames feds for vaccine delay
Log in
NASDAQ:PCVX

Vaxcyte News Headlines

$25.70
-0.13 (-0.50 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.69
Now: $25.70▼
$26.15
50-Day Range
$25.80
MA: $29.34▼
$34.64
52-Week Range
$17.80
Now: $25.70▼
$58.47
Volume194,163 shs
Average Volume282,136 shs
Market Capitalization$1.31 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Vaxcyte (NASDAQ PCVX) News Headlines Today

Source:
SourceHeadline
Vaxcyte, Inc. (NASDAQ:PCVX) Director Robert Lorne Hopfner Sells 29,110 SharesVaxcyte, Inc. (NASDAQ:PCVX) Director Robert Lorne Hopfner Sells 29,110 Shares
americanbankingnews.com - January 14 at 4:46 AM
Vaxcyte, Inc. (NASDAQ:PCVX) Director Sells $1,313,665.70 in StockVaxcyte, Inc. (NASDAQ:PCVX) Director Sells $1,313,665.70 in Stock
americanbankingnews.com - January 14 at 4:14 AM
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells 2,500 Shares of StockInsider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells 2,500 Shares of Stock
americanbankingnews.com - January 13 at 4:16 AM
Robert Lorne Hopfner Sells 57,420 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) StockRobert Lorne Hopfner Sells 57,420 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock
americanbankingnews.com - January 8 at 9:10 PM
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) Director Sells 40,612 Shares of StockInsider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) Director Sells 40,612 Shares of Stock
americanbankingnews.com - January 8 at 8:38 PM
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of "Hold" from BrokeragesVaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of "Hold" from Brokerages
americanbankingnews.com - January 8 at 3:44 AM
Vaxcyte (NASDAQ:PCVX) Stock Price Down 5.7%Vaxcyte (NASDAQ:PCVX) Stock Price Down 5.7%
americanbankingnews.com - January 7 at 9:14 PM
Vaxcyte (NASDAQ:PCVX) Stock Price Up 6.6%Vaxcyte (NASDAQ:PCVX) Stock Price Up 6.6%
americanbankingnews.com - January 6 at 10:02 PM
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep InfectionsVaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
finance.yahoo.com - January 6 at 2:31 PM
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Grant Pickering Sells 15,000 SharesVaxcyte, Inc. (NASDAQ:PCVX) CEO Grant Pickering Sells 15,000 Shares
americanbankingnews.com - December 22 at 11:46 PM
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial OfficerVaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
finance.yahoo.com - December 22 at 1:16 PM
Is PCVX A Good Stock To Buy Now?Is PCVX A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 8:42 PM
U.S. IPO Week Ahead: DoorDash And Airbnb Kick Off The Unicorn Parade In A 6 IPO WeekU.S. IPO Week Ahead: DoorDash And Airbnb Kick Off The Unicorn Parade In A 6 IPO Week
seekingalpha.com - December 6 at 4:14 PM
IPO Calendar: December 7 - 11, 2020IPO Calendar: December 7 - 11, 2020
thestreet.com - December 5 at 11:23 PM
Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx ConferenceVaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
finance.yahoo.com - November 24 at 7:07 PM
Vaxcyte to Present at Jefferies Virtual London Healthcare ConferenceVaxcyte to Present at Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 5:31 PM
We're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To GrowWe're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow
finance.yahoo.com - September 14 at 2:46 PM
Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare ConferenceVaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 10 at 10:03 AM
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business UpdateVaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 12 at 5:13 PM
CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business UpdateCORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 12 at 5:13 PM
Vaccine maker Vaxcyte upsizes IPO and prices at top end of rangeVaccine maker Vaxcyte upsizes IPO and prices at top end of range
finance.yahoo.com - June 19 at 11:36 AM
Vaccine maker Vaxcyte's shares soar 22% in trading debutVaccine maker Vaxcyte's shares soar 22% in trading debut
finance.yahoo.com - June 19 at 11:36 AM
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesVaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 19 at 11:36 AM
This page was last updated on 1/16/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.